TY - JOUR
T1 - Association between ionised calcium and severity of postpartum haemorrhage
T2 - a retrospective cohort study
AU - Epstein, Danny
AU - Solomon, Neta
AU - Korytny, Alexander
AU - Marcusohn, Erez
AU - Freund, Yaacov
AU - Avrahami, Ron
AU - Neuberger, Ami
AU - Raz, Aeyal
AU - Miller, Asaf
N1 - Publisher Copyright:
© 2020 British Journal of Anaesthesia
PY - 2021/5
Y1 - 2021/5
N2 - Background: Postpartum haemorrhage (PPH) is often complicated by impaired coagulation. We aimed to determine whether the level of ionised calcium (Ca2+), an essential coagulation co-factor, at diagnosis of PPH is associated with bleeding severity. Methods: This was a retrospective cohort study of women diagnosed with PPH during vaginal delivery between January 2009 and April 2020. Ca2+ levels at PPH diagnosis were compared between women who progressed to severe PPH (primary outcome) and those with less severe bleeding. Severe PPH was defined by transfusion of ≥2 blood units, arterial embolisation or emergency surgery, admission to ICU, or death. Associations between other variables (e.g. fibrinogen concentration) and bleeding severity were also assessed. Results: For 436 patients included in the analysis, hypocalcaemia was more common among patients with severe PPH (51.5% vs 10.6%, P<0.001). In a multivariable logistic regression model, Ca2+ and fibrinogen were the only parameters independently associated with PPH severity with odds ratios of 1.14 for each 10 mg dl−1 decrease in fibrinogen (95% confidence interval [CI], 1.05–1.24; P=0.002) and 1.97 for each 0.1 mmol L−1 decrease in Ca2+ (95% CI, 1.25–3.1; P=0.003). The performance of Ca2+ or fibrinogen was not significantly different (area under the curve [AUC]=0.79 [95% CI, 0.75–0.83] vs AUC=0.86 [95% CI, 0.82–0.9]; P=0.09). The addition of Ca2+ to fibrinogen improved the model, leading to AUC of 0.9 (95% CI, 0.86–0.93), P=0.03. Conclusions: Ca2+ level at the time of diagnosis of PPH was associated with risk of severe bleeding. Ca2+ monitoring may facilitate identification and treatment of high-risk patients.
AB - Background: Postpartum haemorrhage (PPH) is often complicated by impaired coagulation. We aimed to determine whether the level of ionised calcium (Ca2+), an essential coagulation co-factor, at diagnosis of PPH is associated with bleeding severity. Methods: This was a retrospective cohort study of women diagnosed with PPH during vaginal delivery between January 2009 and April 2020. Ca2+ levels at PPH diagnosis were compared between women who progressed to severe PPH (primary outcome) and those with less severe bleeding. Severe PPH was defined by transfusion of ≥2 blood units, arterial embolisation or emergency surgery, admission to ICU, or death. Associations between other variables (e.g. fibrinogen concentration) and bleeding severity were also assessed. Results: For 436 patients included in the analysis, hypocalcaemia was more common among patients with severe PPH (51.5% vs 10.6%, P<0.001). In a multivariable logistic regression model, Ca2+ and fibrinogen were the only parameters independently associated with PPH severity with odds ratios of 1.14 for each 10 mg dl−1 decrease in fibrinogen (95% confidence interval [CI], 1.05–1.24; P=0.002) and 1.97 for each 0.1 mmol L−1 decrease in Ca2+ (95% CI, 1.25–3.1; P=0.003). The performance of Ca2+ or fibrinogen was not significantly different (area under the curve [AUC]=0.79 [95% CI, 0.75–0.83] vs AUC=0.86 [95% CI, 0.82–0.9]; P=0.09). The addition of Ca2+ to fibrinogen improved the model, leading to AUC of 0.9 (95% CI, 0.86–0.93), P=0.03. Conclusions: Ca2+ level at the time of diagnosis of PPH was associated with risk of severe bleeding. Ca2+ monitoring may facilitate identification and treatment of high-risk patients.
KW - coagulation
KW - fibrinogen
KW - hypocalcaemia
KW - ionised calcium
KW - postpartum haemorrhage
UR - http://www.scopus.com/inward/record.url?scp=85097784700&partnerID=8YFLogxK
U2 - 10.1016/j.bja.2020.11.020
DO - 10.1016/j.bja.2020.11.020
M3 - ???researchoutput.researchoutputtypes.contributiontojournal.article???
C2 - 33341222
AN - SCOPUS:85097784700
SN - 0007-0912
VL - 126
SP - 1022
EP - 1028
JO - British Journal of Anaesthesia
JF - British Journal of Anaesthesia
IS - 5
ER -